PDS Biotechnology (PDSB) Non-Current Assets (2014 - 2026)
PDS Biotechnology's Non-Current Assets came in at $1.76 million for Q2 2026, down 74.2% from $6.83 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, PDS Biotechnology's Non-Current Assets was $2.24 million, up 636.3% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $304,214 in FY2024 (-9.2%), $335,005 in FY2023 (-36.5%), $527,533 in FY2022 (+47.5%) and $357,697 in FY2021 (-35.3%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q4 2024.
- Year-over-year, Non-Current Assets increased in 1 of the last four quarters, with growth averaging 136.1%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2025 (growth of 636.3%), and the weakest in Q2 2026 (a decline of 74.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | PDS Biotechnology | 69.30 Mn | -21.12 Mn | - | 1.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 6.81 Mn |
| Jun 30, 2025 | 6.83 Mn |
| Mar 31, 2025 | 4.56 Mn |
| Dec 31, 2024 | 304,214.00 |
| Sep 30, 2024 | 319,342.00 |
| Jun 30, 2024 | 334,471.00 |
| Mar 31, 2024 | 320,601.00 |
| Dec 31, 2023 | 335,005.00 |
| Sep 30, 2023 | 349,409.00 |
| Jun 30, 2023 | 403,301.00 |
| Mar 31, 2023 | 475,259.00 |
| Dec 31, 2022 | 527,533.00 |
| Sep 30, 2022 | 475,416.00 |
| Jun 30, 2022 | 258,188.00 |
| Mar 31, 2022 | 308,327.00 |
| Dec 31, 2021 | 357,697.00 |
| Sep 30, 2021 | 407,208.00 |
| Jun 30, 2021 | 456,336.00 |
API Access
PDS Biotechnology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();